Vascular endothelial growth factor blocking agents in retinal vein occlusion
This paper summarises the current status of the use of vascular endothelial growth factor (VEGF) blocking agents in retinal vein occlusion.There have been no randomised controlled trials comparing this treatment with the current standard treatment (largely Arch Door Mirror laser) so the lower grade evidence of single treatment case series and anecd